Noerr has advised Irish clinical research company Icon Plc on EU merger clearance for its acquisition of PRA Health Sciences. Schima Mayer Starlinger advised Icon on Austrian law, while A&L Goodbody, Cahill Gordon & Reindel, Macfarlanes, Darrois Villey Maillot Brochier, and Gianni & Origoni advised on Irish, US, UK, French, and Italian law, respectively.
According to Noerr, “the purchase price is approximately USD 12 billion. For the acquisition, Icon has offered PRA shareholders USD 80 per share and 0.4125 Icon shares.” According to the firm, “the takeover makes Icon one of the world’s leading providers among clinical research organizations.”
Noerr’s team included Budapest-based Partners Edina Schweizer and Joerg Menzer, Moscow-based Associated Partner Stefan Weber and Senior Associate Artem Kara, Brussels-based Co-Managing Partner Jens Peter Schmidt and Senior Associate Philipp Studt, and Frankfurt-based Partner Fabian Badtke and Associate Sascha Giller.
Schima Mayer Starlinger’s team included Partners Christian Mayer and Moritz Am Ende and Associate Elisabeth Wielinger.
